COLL · Collegium Pharmaceutical, Inc
$28.23
+0.08 (+0.28%)
At close · Aug 14
Market Cap
$919.04M
Shares
32.56M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Remaining Authorization
$150,000,000
as of 2026-06-30
Program Utilization
-0.0%
$0 used of $150,000,000
| Program Announced | Authorized | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-07-01 | $150,000,000 | $150,000,000 | 2026-06-30 | 2026-12-31 | 8-K , filed 2026-08-13 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2025-12-31 | $25,104,000 | 10-K, filed 2026-02-26 |
| 2024-12-31 | $60,025,000 | 10-K, filed 2026-02-26 |
| 2023-12-31 | $75,000,000 | 10-K, filed 2026-02-26 |
| 2022-12-31 | $14,063,000 | 10-K, filed 2025-02-27 |
| 2021-12-31 | $47,861,000 | 10-K, filed 2024-02-22 |
Key facts
CIK
1267565
CUSIP
19459J104
13F (30d)
270 filings
264 filers
Visit website
Investor relations